The French healthtech start-up raised a €480m series G funding round

Alan, a French health tech company, has successfully attracted a whopping $460 million investment from the Netherlands-based Prosus, elevating its valuation to an impressive $6.3…

Its new funding round values Alan at €5.5bn.